Search research articles
Contact Us
Filters
Showing results (111-120 of 142) with videos related to
Page
of 15
Sort By:
Nature Communications
|
January 9, 2020
Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains
Amanda Khoury, Joanna Achinger-Kawecka, Saul A Bert, et al.
Nucleic Acids Research
|
May 26, 2020
Macrophage development and activation involve coordinated intron retention in key inflammatory regulators
Immanuel D Green, Natalia Pinello, Renhua Song, et al.
Genome Research
|
April 8, 2016
Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations
Phillippa C Taberlay, Joanna Achinger-Kawecka, Aaron T L Lun, et al.
Plos Genetics
|
January 3, 2020
ELF5 modulates the estrogen receptor cistrome in breast cancer
Catherine L Piggin, Daniel L Roden, Andrew M K Law, et al.
Molecular Cancer Therapeutics
|
July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer
Andrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation
Rochelle L Tiedemann, Joel Hrit, Qian Du, et al.
Cell Stem Cell
|
December 9, 2017
Transient and Permanent Reconfiguration of Chromatin and Transcription Factor Occupancy Drive Reprogramming
Anja S Knaupp, Sam Buckberry, Jahnvi Pflueger, et al.
Breast Cancer Research : BCR
|
June 14, 2015
MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene
Yu Wei Phua, Akira Nguyen, Daniel L Roden, et al.
Therapeutic Advances in Medical Oncology
|
April 25, 2022
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel <i>versus</i> standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)
Ciara Conduit, Blossom Mak, Wenjia Qu, et al.
Nucleic Acids Research
|
November 28, 2024
UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation
Rochelle L Tiedemann, Joel Hrit, Qian Du, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 142) with videos related to
Sort By:
Page
of 15
Nature Communications
|
January 9, 2020
Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains
Amanda Khoury, Joanna Achinger-Kawecka, Saul A Bert, et al.
Nucleic Acids Research
|
May 26, 2020
Macrophage development and activation involve coordinated intron retention in key inflammatory regulators
Immanuel D Green, Natalia Pinello, Renhua Song, et al.
Genome Research
|
April 8, 2016
Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations
Phillippa C Taberlay, Joanna Achinger-Kawecka, Aaron T L Lun, et al.
Plos Genetics
|
January 3, 2020
ELF5 modulates the estrogen receptor cistrome in breast cancer
Catherine L Piggin, Daniel L Roden, Andrew M K Law, et al.
Molecular Cancer Therapeutics
|
July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer
Andrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation
Rochelle L Tiedemann, Joel Hrit, Qian Du, et al.
Cell Stem Cell
|
December 9, 2017
Transient and Permanent Reconfiguration of Chromatin and Transcription Factor Occupancy Drive Reprogramming
Anja S Knaupp, Sam Buckberry, Jahnvi Pflueger, et al.
Breast Cancer Research : BCR
|
June 14, 2015
MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene
Yu Wei Phua, Akira Nguyen, Daniel L Roden, et al.
Therapeutic Advances in Medical Oncology
|
April 25, 2022
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel <i>versus</i> standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)
Ciara Conduit, Blossom Mak, Wenjia Qu, et al.
Nucleic Acids Research
|
November 28, 2024
UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation
Rochelle L Tiedemann, Joel Hrit, Qian Du, et al.
Page
of 15